☆ 4.3 Article

Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps

JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Otorhinolaryngology

Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis

Andrew Thamboo et al.

Summary: The study explored the potential benefits of biologic therapy in managing Chronic Rhinosinusitis, specifically focusing on Type 2 inflammatory pathway components. Through a Delphi Method process involving 17 fellowship trained rhinologists in Canada, consensus was achieved on 11 statements to guide Canadian physicians on the use of biologics in CRS patients. Additional updates to the guidance will be provided as more biologics become available and more trials are conducted.

JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2021)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert et al.

LANCET (2019)

添加到收藏夹

Review Medicine, Research & Experimental

Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician

Lawrence Blonde et al.

ADVANCES IN THERAPY (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Prevalence of Polyp Recurrence After Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyposis

Adam S. DeConde et al.

LARYNGOSCOPE (2017)

添加到收藏夹

Article Medicine, Research & Experimental

Role of Frontal Sinus Surgery in Nasal Polyp Recurrence

Ahmed Bassiouni et al.

LARYNGOSCOPE (2013)

添加到收藏夹

Article Otorhinolaryngology

Psychometric validity of the 22-item Sinonasal Outcome Test

C. Hopkins et al.

CLINICAL OTOLARYNGOLOGY (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.